These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 315126)

  • 1. [Ocular complications after treatment with antimalarial agents in dermatology].
    Mikkelsen J
    Ugeskr Laeger; 1979 Aug; 141(34):2316-8. PubMed ID: 315126
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalarials for children: indications, toxicities, and guidelines.
    Ziering CL; Rabinowitz LG; Esterly NB
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):764-70. PubMed ID: 8496422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 4. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of juvenile rheumatoid arthritis with chloroquine phosphate and hydroxychloroquine sulphate. Dosage of syrup and tablets with determinations of serum concentrations].
    Laaksonen AL; Sunell JE; Juva K
    Nord Med; 1971 Mar; 85(12):362-8. PubMed ID: 5574957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of the long-term treatment of skin diseases with corticosteroids].
    Starzycki Z; Dembińska B
    Przegl Dermatol; 1983; 70(4):423-8. PubMed ID: 6669715
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Corneal lesions of the "whirling dystrophy" kind during treatment with chloroquine salt].
    Bonnet I; Dorne PA
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):533-4. PubMed ID: 5312147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs].
    Ochsendorf FR; Runne U
    Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK.
    Kay EA; Rees JA; Jayson MI
    Br J Rheumatol; 1987 Oct; 26(5):375-8. PubMed ID: 3664163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 15. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chloroquine retinopathy: avoidable by individualized daily dosing].
    Ochsendorf FR; Runne U; Goerz G; Zrenner E
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.